Biological effects of decreasing RBM15 on chronic myelogenous leukemia cells

References

• Deininger MW, Goldman JM, Melo JV. The molecular biology of chronic myeloid leukemia. Blood 2000;96:3343–3356.
   PubMed Web of Science ®Google Scholar
• Benekli M, Baer MR, Baumann H, . Signal transducer and activator of transcription proteins in leukemias. Blood 2003;101: 2940–2954.
   PubMed Web of Science ®Google Scholar
• Savage DG, Antman KH. Imatinib mesylate—a new oral targeted therapy. N Engl J Med 2002;346:683–693.
   PubMed Web of Science ®Google Scholar
• Gorre ME, Mohammed M, Ellwood K, . Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification. Science 2001;293:876–880.
   PubMed Web of Science ®Google Scholar
• Branford S, Rudzki Z, Walsh S, . High frequency of point mutations clustered within the adenosine triphosphate-binding region of BCR/ABL in patients with chronic myeloid leukemia or Ph-positive acute lymphoblastic leukemia who develop imatinib (STI571) resistance. Blood 2002;99:3472–3475.
   PubMed Web of Science ®Google Scholar
• Rebay I, Chen F, Hsiao F, . A genetic screen for novel components of the Ras/mitogenactivated protein kinase signaling pathway that interact with the yan gene of Drosophila identifies split ends, a new RNA recognition motif-containing protein. Genetics 2000;154:695–712.
   PubMed Web of Science ®Google Scholar
• Chang JL, Lin HV, Blauwkamp TA, . Spenito and split ends act redundantly to promote Wingless signaling. Dev Biol 2008;314:100–111.
   PubMed Web of Science ®Google Scholar
• Feng Y, Bommer GT, Zhai Y, . Drosophila split ends homologue SHARP functions as a positive regulator of Wnt/beta-catenin/T-cell factor signaling in neoplastic transformation. Cancer Res 2007;67:482–491.
   PubMed Web of Science ®Google Scholar
• Kuroda K, Han H, Tani S, . Regulation of marginal zone B cell development by MINT, a suppressor of Notch/RBP-J signaling pathway. Immunity 2003;18:301–312.
   PubMed Web of Science ®Google Scholar
• Lane ME, Elend M, Heidmann D, . A screen for modifiers of cyclin E function in Drosophila melanogaster identifies Cdk2 mutations, revealing the insignificance of putative phosphorylation sites in Cdk2. Genetics 2000;155:233–244.
   PubMed Web of Science ®Google Scholar
• Wiellette EL, Harding KW, Mace KA, . Spen encodes an RNP motif protein that interacts with Hox pathways to repress the development of head-like sclerites in the Drosophila trunk. Development 1999;126:5373–5385.
   PubMed Web of Science ®Google Scholar
• Chen F, Rebay I. Split ends, a new component of the Drosophila EGF receptor pathway, regulates development of midline glial cells. Curr Biol 2000;10:943–946.
   PubMed Web of Science ®Google Scholar
• Raffel GD, Mercher T, Shigematsu H, . Ott1 (Rbm15) has pleiotropic roles in hematopoietic development. Proc Natl Acad Sci USA 2007;104:6001–6006.
   PubMed Web of Science ®Google Scholar
• Niu C, Zhang J, Breslin P, . c-Myc is a target of RNA-binding motif protein 15 in the regulation of adult hematopoietic stem cell and megakaryocyte development. Blood 2009;114:2087–2096.
   PubMed Web of Science ®Google Scholar
• Raffel GD, Chu GC, Jesneck JL, . Ott1 (Rbm15) is essential for placental vascular branching morphogenesis and embryonic development of the heart and spleen. Mol Cell Biol 2009;29:333–341.
   PubMed Web of Science ®Google Scholar
• Jemc J, Rebay I. Characterization of the split ends-like gene spenito reveals functional antagonism between SPOC family members during Drosophila eye development. Genetics 2006;173: 279–286.
   PubMed Web of Science ®Google Scholar
• Ma, X, Renda MJ, Wang L, . Rbm15 modulates Notch-induced transcriptional activation and affects myeloid differentiation. Mol Cell Biol 2007;27:3056–3064.
   PubMed Web of Science ®Google Scholar
• Oswald F, Kostezka U, Astrahantseff K, . SHARP is a novel component of the Notch/RBP-Jκ signalling pathway. EMBO J 2002;21: 5417–5426.
   PubMed Web of Science ®Google Scholar
• Bray S, Bernard F. Notch targets and their regulation. Curr Top Dev Biol 2010;92:253–275.
   PubMed Web of Science ®Google Scholar
• Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 2002; 296:550–553.
   PubMed Web of Science ®Google Scholar
• Brummelkamp TR, Bernards R, Agami. Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cell 2002;2: 243–247.
   PubMed Web of Science ®Google Scholar
• Kasschau KD, Carrington JC. A counterdefensive strategy of plant viruses: suppression of posttranscriptional gene silencing. Cell 1998;95:461–470.
   PubMed Web of Science ®Google Scholar
• de Pooter RF, Schmitt TM, de la Pompa JL, . Notch signaling requires GATA-2 to inhibit myelopoiesis from embryonic stem cells and primary hemopoietic progenitors. J Immunol 2006;176:5267–5275.
   PubMed Web of Science ®Google Scholar
• Krause DS. Regulation of hematopoietic stem cell fate. Oncogene 2002;21:3262–3269.
   PubMed Web of Science ®Google Scholar
• Radtke F, Wilson A, Mancini SJ, . Notch regulation of lymphocyte development and function. Nat Immunol 2004;5: 247–253.
   PubMed Web of Science ®Google Scholar
• Pancewicz J, Nicot C. Current views on the role of Notch signaling and the pathogenesis of human leukemia. BMC Cancer 2011; 11:502.
   PubMed Web of Science ®Google Scholar